Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder, typically
characterized by anovulation, infertility, obesity, insulin resistance, and polycystic ovaries …

Objective: Women with polycystic ovary syndrome (PCOS) often have cardiovascular
disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE …

Objective: The aim was to formulate practice guidelines for the diagnosis and treatment of
polycystic ovary syndrome (PCOS). Participants: An Endocrine Society-appointed Task …

OBJECTIVE: To perform a review and metaanalysis of the studies evaluating the status of
serum inflammatory markers in women with polycystic ovary syndrome (PCOS). DESIGN …

Objective This guideline will provide the practicing endocrinologist with an approach to the
assessment and treatment of dyslipidemia in patients with endocrine diseases, with the …

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of
reproductive age. Metabolic sequelae associated with PCOS range from insulin resistance …

PCOS is not only the most frequent cause of oligomenorrhea in young women, but also a
metabolic disorder characterized by insulin resistance, glucose intolerance, dyslipidemia …

Dyslipidemia is a very common metabolic abnormality in women with polycystic ovary
syndrome (PCOS). Insulin resistance is a key pathophysiology of PCOS, thus dyslipidemia …

Background Statins are extensively used for cardiovascular disease prevention. Statins
reduce mortality rates more than other lipid-modulating drugs, although evidence from …

The major public health concern worldwide is coronary heart disease, with dyslipidemia as a
major risk factor. Statin drugs are recommended by several guidelines for both primary and …